Merit Medical Systems (NASDAQ: MMSI) reported Q3 EPS of $0.32, $0.02 better than the analyst estimate of $0.30. Revenue for the quarter came in at $179.3 million versus the consensus estimate of $181.31 million.

• Q3 2017 worldwide revenue of $179.3 million ($178.3 million on a comparable, constant currency* basis), up 14.2% as reported (up 13.6% on a comparable, constant currency* basis) over Q3 2016
• YTD 2017 worldwide revenue of $537.0 million ($539.1 million on a comparable, constant currency* basis), up 20.4% as reported (up 20.8% on a comparable, constant currency* basis) over the same period in 2016
• Q3 2017 core revenue* up 5.1% over Q3 2016 core revenue* (core revenue* up 4.5% on a comparable, constant currency* basis); YTD 2017 core revenue* up 8.6% over core revenue* for the same period of 2016 (core revenue* up 8.9% on a comparable, constant currency* basis)
• Q3 2017 GAAP EPS was a loss of $(0.07), compared to income of $0.02 in Q3 2016
• Q3 2017 non-GAAP EPS* was $0.32, compared to $0.26 in Q3 2016
• Q3 2017 GAAP gross margin was 44.9%, compared to 43.2% in Q3 2016
• Q3 2017 non-GAAP gross margin* was 48.1%, compared to 46.8% for Q3 2016

For earnings history and earnings-related data on Merit Medical Systems (MMSI) click here.